iShares Biotechnology ETF

IBB
$205.29 (- $0.67 - 0.33%)
Last updated: 2026-10-02 21:07 UTC
IBB Metrics
Exchange
🇺🇸 NASDAQ XNMS
Nasdaq/NMS (Global Market)United StatesAmerica/New_York
SectorHealth
IndustryiShares
ISINUS4642875565
CUSIP464287556
Market Price205.29
Dividend Yield 0.02%
Dividend Growth
1Y +27.59%
3Y +11.90%
5Y +2.50%
10Y +14.81%
Annual Dividend 0.34
Latest Payout ($)0.01
Latest Payout Date2026-09-18
Dividend FrequencyQuarterly
P/E Ratio23.15
EPS6.89
Market Cap$7.8B
Book Value161.64
Price to Book1.064
Beta0.97
52w High174.4
52w Low107.43
Next Earnings DateN/A

iShares Biotechnology ETF trades under ticker IBB on NASDAQ as an ETF. Use this page to review its market price, share price, dividends, and price history. The page also shows Health exposure. Identifiers: ISIN US4642875565, CUSIP 464287556.

Related researchIBB ETF priceIBB share priceIBB dividend historyIBB dividend yieldiShares Biotechnology ETF dividend historyiShares Biotechnology ETF dividend yield464287556iShares Biotechnology ETFiShares Biotechnology ETF share price
About the Company
iShares Biotechnology ETF is an exchange-traded fund that provides broad exposure to U.S.-listed biotechnology companies. The fund is designed to track a biotechnology-focused index and typically holds a diversified basket of large, mid, and smaller biotechnology names, along with select life sciences tools and services companies that support drug discovery and research. Its portfolio includes firms involved in areas such as therapeutics, genetic medicine, diagnostics, and advanced research platforms. By concentrating on the biotechnology segment, iShares Biotechnology ETF serves as a sector-specific instrument for investors seeking access to one of the most research-intensive areas of the healthcare market. The fund is used by market participants as a way to gain diversified exposure to companies developing innovative medicines and scientific technologies within the healthcare industry.
Price History